At its recent Board meeting, 5 December 2013, the Board approved Alister Craig, Liverpool School of Tropical Medicine as Chair of EVI SAC.
Two Vice Chairs were also approved: Long time member, Ingileif Jónsdóttir, Landspitali University Hospital and Faculty of Medicine, University of Iceland, and James Robertson, retired, who joined SAC this year.
The new Chair of the Board is Clemens Kocken, Biomedical Primate Research Centre
14 November 2013 sees the launch by EVI and WHO and the Malaria Vaccine Funders Group of the updated Malaria Vaccine Technology Roadmap
Link to full text in The Lancet
Medical Research Council (MRC) announces the captioned two week course to be held at the Uganda Virus Research Institute (UVRI), Entebbe.
The EVI Annual Report 2012 is just one click away.
An inter-active user friendly version on a USB stick will be widely distributed during the coming days. Would you like to receive a copy, but are not sure whether you are on the mailing list, please contactusateuvaccine.eu.
EVI round table on "The Challenge of Developing a Pregnancy Associated Malaria Vaccine" was a great success with many comments and an active discussion among the 70-80 participants.
The National Institute for Biological Standards and Control (NIBSC) has an open position for a Principal Scientist specialised in immunology and parasitology to lead malaria research in NIBSC.
TBVI is happy to announce a Call for application for TB vaccine evaluation. TBVI supports testing the protective efficacy and assessing the immunogenicity of new vaccine candidates in a Non-Human Primate (NHP) experiment.
EVI takes great pleasure in welcoming James Robertson who brings among others, regulatory expertise to EVI SAC. EVI likewise welcomes Jean-Paul Prieels, whose industrial experience will be of great benefit to EVI Board of Stakeholders.
- 1 of 11